Latest news and articles about Wanglaoji
Total: 1 articles found
China’s Guangzhou Pharmaceutical Group has publicly announced the conviction or disciplining of 17 executives in a corruption probe involving more than RMB200 million. The cases, which include bribery, kickbacks and the sale of counterfeit medicines, focus heavily on advertising, procurement and distribution channels within the state‑owned group and its Wanglaoji subsidiary.
